Page 1

Logo NEWS RELEASE Omnicell Announces Financial Results for Second Quarter 2021 7/29/2021 Record revenues of $ 273 million GAAP net income per diluted share of $ 0.43 Record non - GAAP net income per diluted share of $ 0.97 MOUNTAIN VIEW , Calif .-- ( BUSINESS WIRE ) -- Omnicell , Inc. ( NASDAQ : OMCL ) , a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies , today announced results for its second quarter ended June 30 , 2021 . GAAP Results Total revenues for the second quarter of 2021 were $ 272.7 million , up $ 73.1 million , or 36.6 % , from the second quarter of 2020. The increase in revenues reflects momentum in our commercial business and strong customer implementations as well as recovery from the impact of COVID - 19 relative to the second quarter of 2020. Total revenues for the six months ended June 30 , 2021 were $ 524.6 million , up $ 95.3 million , or 22.2 % , from the six months ended June 30 , 2020 . Second quarter 2021 GAAP net income was $ 20.4 million , or $ 0.43 per diluted share . This compares to GAAP net loss of $ 4.3 million , or $ 0.10 per diluted share , for the second quarter of 2020 . GAAP net income for the six months ended June 30 , 2021 was $ 34.6 million , or $ 0.74 per diluted share . This compares to GAAP net income of $ 7.0 million , or $ 0.16 per diluted share , for the six months ended June 30 , 2020 . Non - GAAP Results Non - GAAP net income for the second quarter of 2021 was $ 44.1 million , or $ 0.97 per diluted share . This compares to non - GAAP net income of $ 15.9 million , or $ 0.37 per diluted share , for the second quarter of 2020 . 1